Dr Agarwals Eye Hosp
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Aug 3 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.NS:
DR AGARWAL'S EYE HOSPITAL LTD JUNE-QUARTER NET PAT 233.8 MILLION RUPEES
DR AGARWAL'S EYE HOSPITAL LTD JUNE-QUARTER REVENUE FROM OPERATIONS 1.43 BILLION RUPEES
Source text: ID:nBSE2tXQMl
Further company coverage: DRAG.NS
(([email protected];))
Aug 3 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.NS:
DR AGARWAL'S EYE HOSPITAL LTD JUNE-QUARTER NET PAT 233.8 MILLION RUPEES
DR AGARWAL'S EYE HOSPITAL LTD JUNE-QUARTER REVENUE FROM OPERATIONS 1.43 BILLION RUPEES
Source text: ID:nBSE2tXQMl
Further company coverage: DRAG.NS
(([email protected];))
Feb 3 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD DEC-QUARTER NET PAT 172.8 MILLION RUPEES
DR AGARWAL'S EYE HOSPITAL LTD DEC-QUARTER REVENUE FROM OPERATIONS 1.16 BILLION RUPEES
Source text: [ID:]
Further company coverage: DRAG.BO
(([email protected];))
Feb 3 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD DEC-QUARTER NET PAT 172.8 MILLION RUPEES
DR AGARWAL'S EYE HOSPITAL LTD DEC-QUARTER REVENUE FROM OPERATIONS 1.16 BILLION RUPEES
Source text: [ID:]
Further company coverage: DRAG.BO
(([email protected];))
Oct 29 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD - DIVIDEND OF 2.50 RUPEES PER SHARE
Source text: ID:nBSE42jyZh
Further company coverage: DRAG.BO
(([email protected];;))
Oct 29 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD - DIVIDEND OF 2.50 RUPEES PER SHARE
Source text: ID:nBSE42jyZh
Further company coverage: DRAG.BO
(([email protected];;))
April 25 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DIVIDEND 2.5 RUPEES PER SHARE
Source text for Eikon: ID:nBSE70tcdG
Further company coverage: DRAG.BO
(([email protected];))
April 25 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DIVIDEND 2.5 RUPEES PER SHARE
Source text for Eikon: ID:nBSE70tcdG
Further company coverage: DRAG.BO
(([email protected];))
Oct 20 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD - DIVIDEND OF 2.5 RUPEES PER SHARE
INDIA'S DR AGARWAL'S EYE HOSPITAL SEPT-QUARTER NET PAT 125.9 MILLION RUPEES VERSUS 90.7 MILLION RUPEES
DR AGARWAL'S EYE HOSPITAL SEPT-QUARTER REVENUE FROM OPERATIONS 832.7 MILLION RUPEES VERSUS 687.5 MILLION RUPEES
Source text for Eikon: ID:nBSE8hH8Vh
Further company coverage: DRAG.BO
(([email protected];))
Oct 20 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
DR AGARWAL'S EYE HOSPITAL LTD - DIVIDEND OF 2.5 RUPEES PER SHARE
INDIA'S DR AGARWAL'S EYE HOSPITAL SEPT-QUARTER NET PAT 125.9 MILLION RUPEES VERSUS 90.7 MILLION RUPEES
DR AGARWAL'S EYE HOSPITAL SEPT-QUARTER REVENUE FROM OPERATIONS 832.7 MILLION RUPEES VERSUS 687.5 MILLION RUPEES
Source text for Eikon: ID:nBSE8hH8Vh
Further company coverage: DRAG.BO
(([email protected];))
CHENNAI, Aug 17 (Reuters) - Dr. Agarwal's Health Care said on Thursday it raised $80 million from existing investors Singapore's Temasek and U.S.-based TPG as the Indian eye hospital operator plans to double its hospital count.
The top shareholder of publicly listed Dr. Agarwal's Eye Hospitals DRAG.BO plans to operate 300 hospitals by the end of 2025. It currently has over 150 hospitals, including in African countries like Nigeria and Kenya.
Shares of Dr. Agarwal's Eye Hospitals rose as much as 10.3% after the announcement, before paring some gains to last trade up 4.2%.
Dr. Agarwal's will invest over 12 billion rupees ($144.45 million) to set up new hospitals in India and 10 centres in the African countries of Kenya, Zambia, and Tanzania, it said in a press release.
The fundraise also comes over a year after Dr. Agarwal's – founded in 1957 in the southern Indian city of Chennai – closed a funding round of 10.50 billion rupees from Temasek and TPG Growth, the middle market-focused arm of TPG TPG.O.
Private care is becoming more and more popular in India due to a growing and ageing population, as well as rise in income levels. The pandemic has sharpened people's focus on health and wellness.
Spotting the trend, global investors are scouting the around $48 billion Indian private healthcare market, with Temasek itself spending $2 billion in April to lift its stake in multi-specialty chain Manipal Hospitals by 41% to 59%.
($1 = 83.0760 Indian rupees)
(Reporting by Praveen Paramasivam in Chennai)
(([email protected]; +91 867-525-3569;))
CHENNAI, Aug 17 (Reuters) - Dr. Agarwal's Health Care said on Thursday it raised $80 million from existing investors Singapore's Temasek and U.S.-based TPG as the Indian eye hospital operator plans to double its hospital count.
The top shareholder of publicly listed Dr. Agarwal's Eye Hospitals DRAG.BO plans to operate 300 hospitals by the end of 2025. It currently has over 150 hospitals, including in African countries like Nigeria and Kenya.
Shares of Dr. Agarwal's Eye Hospitals rose as much as 10.3% after the announcement, before paring some gains to last trade up 4.2%.
Dr. Agarwal's will invest over 12 billion rupees ($144.45 million) to set up new hospitals in India and 10 centres in the African countries of Kenya, Zambia, and Tanzania, it said in a press release.
The fundraise also comes over a year after Dr. Agarwal's – founded in 1957 in the southern Indian city of Chennai – closed a funding round of 10.50 billion rupees from Temasek and TPG Growth, the middle market-focused arm of TPG TPG.O.
Private care is becoming more and more popular in India due to a growing and ageing population, as well as rise in income levels. The pandemic has sharpened people's focus on health and wellness.
Spotting the trend, global investors are scouting the around $48 billion Indian private healthcare market, with Temasek itself spending $2 billion in April to lift its stake in multi-specialty chain Manipal Hospitals by 41% to 59%.
($1 = 83.0760 Indian rupees)
(Reporting by Praveen Paramasivam in Chennai)
(([email protected]; +91 867-525-3569;))
Aug 4 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
JUNE-QUARTER NET PAT 115.4 MILLION RUPEES VERSUS 91.1 MILLION RUPEES YEAR AGO
JUNE-QUARTER REVENUE FROM OPERATIONS 778 MILLION RUPEES VERSUS 663.9 MILLION RUPEES YEAR AGO
Further company coverage: DRAG.BO
(([email protected];))
Aug 4 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
JUNE-QUARTER NET PAT 115.4 MILLION RUPEES VERSUS 91.1 MILLION RUPEES YEAR AGO
JUNE-QUARTER REVENUE FROM OPERATIONS 778 MILLION RUPEES VERSUS 663.9 MILLION RUPEES YEAR AGO
Further company coverage: DRAG.BO
(([email protected];))
May 10 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
FINAL DIVIDEND OF 3 RUPEES PER SHARE
MARCH-QUARTER NET PAT 136.8 MILLION RUPEES VERSUS 68.7 MILLION RUPEES
MARCH-QUARTER REVENUE FROM OPERATIONS 692.1 MILLION RUPEES VERSUS 556.6 MILLION RUPEES
Source text for Eikon: ID:nBSE6hVQdy
Further company coverage: DRAG.BO
(([email protected];))
May 10 (Reuters) - Dr Agarwal's Eye Hospital Ltd DRAG.BO:
FINAL DIVIDEND OF 3 RUPEES PER SHARE
MARCH-QUARTER NET PAT 136.8 MILLION RUPEES VERSUS 68.7 MILLION RUPEES
MARCH-QUARTER REVENUE FROM OPERATIONS 692.1 MILLION RUPEES VERSUS 556.6 MILLION RUPEES
Source text for Eikon: ID:nBSE6hVQdy
Further company coverage: DRAG.BO
(([email protected];))
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Dr Agarwals Eye Hosp do?
Dr Agarwals Eye Hospital Ltd is a leading medical facility in the field of Ophthalmic care, known for its pioneering medical advancements, highly skilled specialists, and a wide range of services including surgeries and customized eye treatments.
Who are the competitors of Dr Agarwals Eye Hosp?
Dr Agarwals Eye Hosp major competitors are Apollo Hospital Ent., Max Healthcare Inst., Fortis Healthcare, Global Health, Narayana Hrudayalay., Krishna Inst.Medi, Aster DM Quality. Market Cap of Dr Agarwals Eye Hosp is ₹2,537 Crs. While the median market cap of its peers are ₹72,476 Crs.
Is Dr Agarwals Eye Hosp financially stable compared to its competitors?
Dr Agarwals Eye Hosp seems to be less financially stable compared to its competitors. Altman Z score of Dr Agarwals Eye Hosp is 5.35 and is ranked 6 out of its 8 competitors.
Does Dr Agarwals Eye Hosp pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Dr Agarwals Eye Hosp latest dividend payout ratio is 5.16% and 3yr average dividend payout ratio is 4.68%
How has Dr Agarwals Eye Hosp allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Dr Agarwals Eye Hosp balance sheet?
Balance sheet of Dr Agarwals Eye Hosp is strong. But short term working capital might become an issue for this company.
Is the profitablity of Dr Agarwals Eye Hosp improving?
Yes, profit is increasing. The profit of Dr Agarwals Eye Hosp is ₹76.22 Crs for TTM, ₹54.65 Crs for Mar 2025 and ₹46.36 Crs for Mar 2024.
Is the debt of Dr Agarwals Eye Hosp increasing or decreasing?
Yes, The net debt of Dr Agarwals Eye Hosp is increasing. Latest net debt of Dr Agarwals Eye Hosp is ₹75.1 Crs as of Mar-26. This is greater than Mar-25 when it was ₹73.22 Crs.
Is Dr Agarwals Eye Hosp stock expensive?
Yes, Dr Agarwals Eye Hosp is expensive. Latest PE of Dr Agarwals Eye Hosp is 33.3, while 3 year average PE is 30.03. Also latest EV/EBITDA of Dr Agarwals Eye Hosp is 17.26 while 3yr average is 14.71.
Has the share price of Dr Agarwals Eye Hosp grown faster than its competition?
Dr Agarwals Eye Hosp has given better returns compared to its competitors. Dr Agarwals Eye Hosp has grown at ~42.38% over the last 3yrs while peers have grown at a median rate of 28.88%
Is the promoter bullish about Dr Agarwals Eye Hosp?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Dr Agarwals Eye Hosp is 72.67% and last quarter promoter holding is 72.67%.
Are mutual funds buying/selling Dr Agarwals Eye Hosp?
The mutual fund holding of Dr Agarwals Eye Hosp is stable. The current mutual fund holding in Dr Agarwals Eye Hosp is 0.03% while previous quarter holding is 0.03%.